The Valley Desk

NCT03318939 · Interventional trial

Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Overall registry status Terminated

Phase 2

Conditions NSCLC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov